Pharma PR: It’s All About Defending Drug Prices
A couple of days ago, I posted a note about pharma sales reps being poor spokespeople for the industry (see "Sales Reps Make Poor...
Sales Reps Make Poor Spokespeople
I read with despair the article in today's AdAge about Glaxo's strategy to use its sales force as a "PR Machine" ("GLAXO DRAFTS EMPLOYEES...
Avastin – Supersize Profiteering!
Speaking of the high cost of drugs, how about Genentech selling Avastin -- a drug used to treat colon cancer and now approved for...
FDA Backs Down on Coupon Study
According to Brandweek ("Advertising: FDA Floats, Then Sinks, Drug Ad Coupon Study" - subscription required), FDA "yanked" its Federal Register notice to conduct studies...
Gen X Reps Revisited
My post yesterday regarding the differences between sales reps of the boomer generation vs. those of the Gen X cohort (see "Generation X Pharma...
Generation X Pharma Reps
I have very little in common with Jamie Reidy, the author of the book "Hard Sell: The Evolution of a Viagra Salesman," which is...
2nd Annual Summit on Post-Marketing Studies
This is the premier forum dedicated entirely to Post-Marketing Studies. Network at, and benefit from, the leading industry event!
Brand Defense and Lifecycle Management for Mature Drugs
Protect Brand Revenue through Defensive Patenting, Franchising, Reformulation and Market Segmentation
FDA, Coupons, and Sleep Aid DTC Ads
According to a short piece in the Wall Street Journal, the FDA "is looking at whether coupons and rebates that are part of some...
Cialis Blog Shut Down
Not exactly shut down, but close enough!A few days ago I reported that cialisblog.com was apparently using the Cialis brand logo without the consent...
